期刊
MOLECULAR CANCER
卷 17, 期 -, 页码 -出版社
BMC
DOI: 10.1186/s12943-018-0759-3
关键词
Chimeric antigen receptor T cell; Adoptive cell therapy; Solid tumor; Immunosuppressive microenvironment; Cancer immunotherapy
资金
- State Key Laboratory of Natural Medicines [SKLNMBZ201403]
- National Science and Technology Major Projects of New Drugs in China [2012ZX09103301-004, 2014ZX09508007]
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)
The potential for adoptive cell immunotherapy as a treatment against cancers has been demonstrated by the remarkable response in some patients with hematological malignancies using autologous T cells endowed with chimeric antigen receptors (CARs) specific for CD19. Clinical efficacy of CAR-T cell therapy for the treatment of solid tumors, however, is rare due to physical and biochemical factors. This review focuses on different aspects of multiple mechanisms of immunosuppression in solid tumors. We characterize the current state of CAR-modified T cell therapy and summarize the various strategies to combat the immunosuppressive microenvironment of solid tumors, with the aim of promoting T cell cytotoxicity and enhancing tumor cell eradication.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据